Acute hemorrhagic diarrhea syndrome (AHDS) in dogs

Acute hemorrhagic diarrhea syndrome (AHDS) in dogs

Alaska husky

In this project, we study the role of the two bacteria Providencia alcalifaciens and Clostridium perfringens which were isolated from sick dogs during the outbreak of acute hemorrhagic diarrhea in the autumn of 2019.

prosjekt

About/Aims
Background

In the autumn of 2019, an increase in cases of acute hemorrhagic diarrhea syndrome (AHDS) in dogs in southeastern Norway was observed, and 42 dogs died without known predisposing factors. Extensive media coverage of "the unknown dog disease" showed that many people are concerned about the health of their dogs and expect veterinary professionals to work to understand the cause(s) of these cases. A wide range of infectious agents, in addition to poisoning, were excluded based on clinical and pathological findings, microbiological examinations and molecular diagnostics. The bacterium Providencia (P.) alcalifaciens was isolated from about 60% of all fecal samples collected and from 75% of autopsied dogs - an unusually high incidence. In most cases, P. alcalifaciens was found together with Clostridium (C.) perfringens. To investigate the underlying causes of the AHDS outbreak, and in particular possible roles for P. alcalifaciens and C. perfringens, a major collaboration was initiated between the paraclinical and clinical institutes at NMBU and the Veterinary Institute.

Acute haemorrhagic diarrhea in dogs is a commonly observed syndrome of unknown etiology. A preliminary diagnosis of "acute hemorrhagic diarrhea syndrome" (AHDS) can be made by ruling out known causes of hemorrhagic diarrhea. During the outbreak of AHDS in the autumn of 2019, the only specific finding was a high incidence of an unusual bacterium, P. alcalifaciens (62%), often in co-occurrence with the common bacterium C. perfringens (36.9%) (Haaland et al., 2020).

Objective

P. alcalifaciens is known to cause foodborne outbreaks of gastrointestinal diseases in humans (Murata et al., 2001; Chlibek et al. 2002; Shah et al. 2014; Shima et al., 2017) and pneumonia in piglets (Wang et al., 2014). It has also been associated with diarrhea in children (Albert et al., 1989; Urbina et al. 2003), and travelers' diarrhea (Haynes og Hawkey, 1989). Furthermore, P. alcalifaciens has been discussed as a cause of enteritis in dogs (Mohr, 2002; Tribe og Rood, 2002; Krol et al. 2007), but this association is controversial. The possible role of the bacterium in diarrhea in dogs in Norway was described for the first time in 2005, when two bioengineering students wrote a bachelor's thesis under the supervision of Parafag's Head of Department Trine L’Abée-Lund (Fauske og Næve, 2006). There are large knowledge gaps in our understanding of the possible role of P. alcalifaciens as a causative agent of AHDS. There is a lack of knowledge about possible virulence properties and pathogenesis, interaction with other bacteria and not least epidemiology. In this project, we use different approaches to gain insight into this bacterium as a primary pathogen, including whole genome sequencing, cell line infection models and metagenomics.

C. perfringens is part of the normal intestinal microbiota of humans and animals and can also be found widely in the environment, and the bacterium is a common finding in dogs with AHDS (Unterer et al., 2014). While disease caused by C. perfringens is generally thought to be of a less severe degree (Marks og Kather, 2006), strains expressing the enterotoxins NetE / NetF have been associated with severe AHDS (Gohari et al. 2015; Sindern et al., 2019). The results from the first study of the outbreak in 2019 did not indicate a major role for NetE / NetF strains (Jørgensen et al., 2021). Now we are working on an in-depth analysis of the outbreak strains of C. perfringens using toxin typing and sequencing of the entire genome. In addition, we will study interactions between C. perfringens and P. alcalifaciens in co-infection.

All infection studies carried out as part of PhD and research line projects use in vitro models in line with the principles for replacement, reduction and improvement of animal experiments.

Our clinical knowledge about acute hemorrhagic diarrhea syndrome (AHDS) and P. alcalifaciens is poor, and there is a need for robust data on treatment options, long-term prognosis and causal relationships.